Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher F Sharpley

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
Psycho-Oncology|February 10, 2016
Trajectories of total depression and depressive symptoms in prostate cancer patients receiving six months of hormone therapyChristopher F Sharpley, David R H Christie, Vicki Bitsika, et al.
Neuroscience and Biobehavioral Reviews|December 27, 2014
Biological determinants of depression following bereavementAmelia A Assareh, Christopher F Sharpley, James R McFarlane, et al.
Reviews in the Neurosciences|February 5, 2018
Gut microbiome and depression: what we know and what we need to knowGal Winter, Robert A Hart, Richard P G Charlesworth, et al.
American Journal of Men'S Health|August 15, 2015
Factor Structure of the Gotland Scale of Male Depression in Two Samples of Men With Prostate Cancer: Implications for Treating Male DepressionChristopher F Sharpley, Vicki Bitsika, David R H Christie, et al.
Psycho-Oncology|February 5, 2017
Using cluster analysis of anxiety-depression to identify subgroups of prostate cancer patients for targeted treatment planningChristopher F Sharpley, Vicki Bitsika, Amelia K Warren, et al.
Psycho-Oncology|May 3, 2014
Differences in major depressive disorder and generalised anxiety disorder symptomatology between prostate cancer patients receiving hormone therapy and those who are notChristopher F Sharpley, Vicki Bitsika, Addie C Wootten, et al.
Behavioural Brain Research|June 9, 2015
Frontal alpha asymmetry as a pathway to behavioural withdrawal in depression: Research findings and issuesEmmanuel Jesulola, Christopher F Sharpley, Vicki Bitsika, et al.
International Journal of Clinical Oncology|December 18, 2013
The effects of low- and high-dose-rate brachytherapy on depressive symptoms in prostate cancer patientsChristopher F Sharpley, David H R Christie, Vicki Bitsika, et al.
International Journal of Psychiatry in Clinical Practice|June 23, 2016
The association between aspects of psychological resilience and subtypes of depression: implications for focussed clinical treatment modelsChristopher F Sharpley, Vicki Bitsika, Emmanuel Jesulola, et al.
Psycho-Oncology|December 12, 2023
Network connectivity between psychological resilience and depression in prostate cancer patientsChristopher F Sharpley, Wayne M Arnold, David R H Christie, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Psycho-Oncology|February 10, 2016
Trajectories of total depression and depressive symptoms in prostate cancer patients receiving six months of hormone therapyChristopher F Sharpley, David R H Christie, Vicki Bitsika, et al.
Neuroscience and Biobehavioral Reviews|December 27, 2014
Biological determinants of depression following bereavementAmelia A Assareh, Christopher F Sharpley, James R McFarlane, et al.
Reviews in the Neurosciences|February 5, 2018
Gut microbiome and depression: what we know and what we need to knowGal Winter, Robert A Hart, Richard P G Charlesworth, et al.
American Journal of Men'S Health|August 15, 2015
Factor Structure of the Gotland Scale of Male Depression in Two Samples of Men With Prostate Cancer: Implications for Treating Male DepressionChristopher F Sharpley, Vicki Bitsika, David R H Christie, et al.
Psycho-Oncology|February 5, 2017
Using cluster analysis of anxiety-depression to identify subgroups of prostate cancer patients for targeted treatment planningChristopher F Sharpley, Vicki Bitsika, Amelia K Warren, et al.
Psycho-Oncology|May 3, 2014
Differences in major depressive disorder and generalised anxiety disorder symptomatology between prostate cancer patients receiving hormone therapy and those who are notChristopher F Sharpley, Vicki Bitsika, Addie C Wootten, et al.
Behavioural Brain Research|June 9, 2015
Frontal alpha asymmetry as a pathway to behavioural withdrawal in depression: Research findings and issuesEmmanuel Jesulola, Christopher F Sharpley, Vicki Bitsika, et al.
International Journal of Clinical Oncology|December 18, 2013
The effects of low- and high-dose-rate brachytherapy on depressive symptoms in prostate cancer patientsChristopher F Sharpley, David H R Christie, Vicki Bitsika, et al.
International Journal of Psychiatry in Clinical Practice|June 23, 2016
The association between aspects of psychological resilience and subtypes of depression: implications for focussed clinical treatment modelsChristopher F Sharpley, Vicki Bitsika, Emmanuel Jesulola, et al.
Psycho-Oncology|December 12, 2023
Network connectivity between psychological resilience and depression in prostate cancer patientsChristopher F Sharpley, Wayne M Arnold, David R H Christie, et al.
Pageof 13